Seok-Jo Kim1, Paul Cheresh1, Renea P Jablonski1, Luisa Morales-Nebreda1, Yuan Cheng1, Erin Hogan1, Anjana Yeldandi2, Monica Chi1, Raul Piseaux3, Karen Ridge1, C Michael Hart4, Navdeep Chandel3, G R Scott Budinger1, David W Kamp5. 1. Department of Medicine, Division of Pulmonary & Critical Care Medicine, Jesse Brown VA Medical Center, Chicago, IL, United States; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States. 2. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States. 3. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States. 4. Atlanta VA Medical Center, Decatur, GA, United States; Department of Medicine, Emory University, Atlanta, GA, United States. 5. Department of Medicine, Division of Pulmonary & Critical Care Medicine, Jesse Brown VA Medical Center, Chicago, IL, United States; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States. Electronic address: d-kamp@northwestern.edu.
Abstract
RATIONALE: Alveolar epithelial cell (AEC) injury and mitochondrial dysfunction are important in the development of lung fibrosis. Our group has shown that in the asbestos exposed lung, the generation of mitochondrial reactive oxygen species (ROS) in AEC mediate mitochondrial DNA (mtDNA) damage and apoptosis which are necessary for lung fibrosis. These data suggest that mitochondrial-targeted antioxidants should ameliorate asbestos-induced lung. OBJECTIVE: To determine whether transgenic mice that express mitochondrial-targeted catalase (MCAT) have reduced lung fibrosis following exposure to asbestos or bleomycin and, if so, whether this occurs in association with reduced AEC mtDNA damage and apoptosis. METHODS: Crocidolite asbestos (100µg/50µL), TiO2 (negative control), bleomycin (0.025 units/50µL), or PBS was instilled intratracheally in 8-10 week-old wild-type (WT - C57Bl/6J) or MCAT mice. The lungs were harvested at 21d. Lung fibrosis was quantified by collagen levels (Sircol) and lung fibrosis scores. AEC apoptosis was assessed by cleaved caspase-3 (CC-3)/Surfactant protein C (SFTPC) immunohistochemistry (IHC) and semi-quantitative analysis. AEC (primary AT2 cells from WT and MCAT mice and MLE-12 cells) mtDNA damage was assessed by a quantitative PCR-based assay, apoptosis was assessed by DNA fragmentation, and ROS production was assessed by a Mito-Sox assay. RESULTS: Compared to WT, crocidolite-exposed MCAT mice exhibit reduced pulmonary fibrosis as measured by lung collagen levels and lung fibrosis score. The protective effects in MCAT mice were accompanied by reduced AEC mtDNA damage and apoptosis. Similar findings were noted following bleomycin exposure. Euk-134, a mitochondrial SOD/catalase mimetic, attenuated MLE-12 cell DNA damage and apoptosis. Finally, compared to WT, asbestos-induced MCAT AT2 cell ROS production was reduced. CONCLUSIONS: Our finding that MCAT mice have reduced pulmonary fibrosis, AEC mtDNA damage and apoptosis following exposure to asbestos or bleomycin suggests an important role for AEC mitochondrial H2O2-induced mtDNA damage in promoting lung fibrosis. We reason that strategies aimed at limiting AEC mtDNA damage arising from excess mitochondrial H2O2 production may be a novel therapeutic target for mitigating pulmonary fibrosis. Published by Elsevier Inc.
RATIONALE: Alveolar epithelial cell (AEC) injury and mitochondrial dysfunction are important in the development of lung fibrosis. Our group has shown that in the asbestos exposed lung, the generation of mitochondrial reactive oxygen species (ROS) in AEC mediate mitochondrial DNA (mtDNA) damage and apoptosis which are necessary for lung fibrosis. These data suggest that mitochondrial-targeted antioxidants should ameliorate asbestos-induced lung. OBJECTIVE: To determine whether transgenic mice that express mitochondrial-targeted catalase (MCAT) have reduced lung fibrosis following exposure to asbestos or bleomycin and, if so, whether this occurs in association with reduced AEC mtDNA damage and apoptosis. METHODS:Crocidolite asbestos (100µg/50µL), TiO2 (negative control), bleomycin (0.025 units/50µL), or PBS was instilled intratracheally in 8-10 week-old wild-type (WT - C57Bl/6J) or MCATmice. The lungs were harvested at 21d. Lung fibrosis was quantified by collagen levels (Sircol) and lung fibrosis scores. AEC apoptosis was assessed by cleaved caspase-3 (CC-3)/Surfactant protein C (SFTPC) immunohistochemistry (IHC) and semi-quantitative analysis. AEC (primary AT2 cells from WT and MCATmice and MLE-12 cells) mtDNA damage was assessed by a quantitative PCR-based assay, apoptosis was assessed by DNA fragmentation, and ROS production was assessed by a Mito-Sox assay. RESULTS: Compared to WT, crocidolite-exposed MCATmice exhibit reduced pulmonary fibrosis as measured by lung collagen levels and lung fibrosis score. The protective effects in MCATmice were accompanied by reduced AEC mtDNA damage and apoptosis. Similar findings were noted following bleomycin exposure. Euk-134, a mitochondrial SOD/catalase mimetic, attenuated MLE-12 cell DNA damage and apoptosis. Finally, compared to WT, asbestos-induced MCATAT2 cell ROS production was reduced. CONCLUSIONS: Our finding that MCATmice have reduced pulmonary fibrosis, AEC mtDNA damage and apoptosis following exposure to asbestos or bleomycin suggests an important role for AEC mitochondrial H2O2-induced mtDNA damage in promoting lung fibrosis. We reason that strategies aimed at limiting AEC mtDNA damage arising from excess mitochondrial H2O2 production may be a novel therapeutic target for mitigating pulmonary fibrosis. Published by Elsevier Inc.
Authors: Marta Bueno; Yen-Chun Lai; Yair Romero; Judith Brands; Claudette M St Croix; Christelle Kamga; Catherine Corey; Jose D Herazo-Maya; John Sembrat; Janet S Lee; Steve R Duncan; Mauricio Rojas; Sruti Shiva; Charleen T Chu; Ana L Mora Journal: J Clin Invest Date: 2014-12-22 Impact factor: 14.808
Authors: Vivian Y Lee; Clara Schroedl; Joslyn K Brunelle; Leonard J Buccellato; Ozkan I Akinci; Hideaki Kaneto; Colleen Snyder; James Eisenbart; G R Scott Budinger; Navdeep S Chandel Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-10 Impact factor: 5.464
Authors: Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei Journal: J Toxicol Environ Health B Crit Rev Date: 2011 Impact factor: 6.393
Authors: Peizhong Mao; Maria Manczak; Marcus J Calkins; Quang Truong; Tejaswini P Reddy; Arubala P Reddy; Ulziibat Shirendeb; Herng-Hsiang Lo; Peter S Rabinovitch; P Hemachandra Reddy Journal: Hum Mol Genet Date: 2012-04-05 Impact factor: 6.150
Authors: Kelly C Teixeira; Fernanda S Soares; Luís G C Rocha; Paulo C L Silveira; Luciano A Silva; Samuel S Valença; Felipe Dal Pizzol; Emilio L Streck; Ricardo A Pinho Journal: Pulm Pharmacol Ther Date: 2007-08-29 Impact factor: 3.410
Authors: Avignat S Patel; Jin Woo Song; Sarah G Chu; Kenji Mizumura; Juan C Osorio; Ying Shi; Souheil El-Chemaly; Chun Geun Lee; Ivan O Rosas; Jack A Elias; Augustine M K Choi; Danielle Morse Journal: PLoS One Date: 2015-03-18 Impact factor: 3.240
Authors: Seok-Jo Kim; Paul Cheresh; Mesut Eren; Renea P Jablonski; Anjana Yeldandi; Karen M Ridge; G R Scott Budinger; Dong-Hyun Kim; Myles Wolf; Douglas E Vaughan; David W Kamp Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-04-20 Impact factor: 5.464
Authors: Carmen Veith; Agnes W Boots; Musa Idris; Frederik-Jan van Schooten; Albert van der Vliet Journal: Antioxid Redox Signal Date: 2019-04-05 Impact factor: 8.401
Authors: Renea P Jablonski; Seok-Jo Kim; Paul Cheresh; David B Williams; Luisa Morales-Nebreda; Yuan Cheng; Anjana Yeldandi; Sangeeta Bhorade; Annie Pardo; Moises Selman; Karen Ridge; David Gius; G R Scott Budinger; David W Kamp Journal: FASEB J Date: 2017-03-03 Impact factor: 5.191
Authors: Seok-Jo Kim; Paul Cheresh; Renea P Jablonski; Lyudmila Rachek; Anjana Yeldandi; Raul Piseaux-Aillon; Mark J Ciesielski; Karen Ridge; Cara Gottardi; Anna P Lam; Annie Pardo; Moises Selman; Viswanathan Natarajan; David W Kamp Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-03-25 Impact factor: 5.464
Authors: Carmen Veith; Milena Hristova; Karamatullah Danyal; Aida Habibovic; Christopher M Dustin; John E McDonough; Bart M Vanaudenaerde; Michael Kreuter; Marc A Schneider; Nicolas Kahn; Frederik J van Schooten; Agnes W Boots; Albert van der Vliet Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-12-16 Impact factor: 5.464